Rallybio to Present at Upcoming Investor Conferences in November
- None.
- None.
-
Stifel 2023 Healthcare Conference in
New York, NY on Wednesday, November 15, 2023. Steve Uden, M.D., Chief Executive Officer will present a corporate overview at 3:00 p.m. EST. -
6th Annual Evercore ISI HealthCONx Conference in
Miami, FL on Tuesday, November 28, 2023. Steve Uden. M.D., Chief Executive Officer will participate in a fireside chat at 7:30 a.m. EST.
Live webcasts of both presentations will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com. A replay of the webcasts will be available for 30 days following each presentation.
About Rallybio
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, an inhibitor of complement component 5 (C5), with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development.
Rallybio is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20231028440323/en/
Investor Contacts
Ami Bavishi
Head of Investor Relations and Communications
475-47-RALLY (Ext. 282)
abavishi@rallybio.com
Hannah Deresiewicz
Stern Investor Relations, Inc.
212-362-1200
hannah.deresiewicz@sternir.com
Media Contact
Jorge Gaeta
Mission North
(516) 430-7659
Rallybio@missionnorth.com
Source: Rallybio Corporation
FAQ
What investor conferences is Rallybio Corporation participating in?
Who will be presenting at the conferences?
Where can the webcasts be accessed?
